Dr. Yvonne Bombard is a genomics health services researcher and Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Unity Health Toronto. She is an Associate Professor at the Institute of Health Policy, Management and Evaluation at the University of Toronto and directs the Genomics Health Services Research Program at St. Michael’s Hospital. Dr. Bombard holds the Canada Research Chair in Genomics Health Services and Policy. She sets research direction at national and international levels as Board Member of the American Society of Human Genetics and CIHR’s Institute of Genetics. Dr. Bombard advises on funding recommendations on emerging genetic testing technologies for Ontario. Dr. Bombard was the inaugural recipient of the Maurice McGregor Award for Demonstrated Excellence and Leadership Potential from the Canadian Agency for Drugs and Technologies in Health (CADTH) and also received a ‘Rising Star’ award from CIHR’s Institute of Health Services and Policy Research. She has been awarded a CIHR Foundation grant as an Early Career Investigator, CIHR Maud Menten Early Career Prize in Genetics and recently received Canadian Cancer Society’s early career investigator award for her work and policy change.

Recent Publications

  1. Kodida, R, Reble, E, Clausen, M, Shickh, S, Mighton, C, Sam, J et al.. A model for the return and referral of all clinically significant secondary findings of genomic sequencing. J Med Genet. 2023; :. doi: 10.1136/jmg-2022-109091. PubMed PMID:37217257 .
  2. Shickh, S, Sebastian, A, Clausen, M, Mighton, C, Elser, C, Eisen, A et al.. Great expectations: patients' preferences for clinically significant results from genomic sequencing. Hum Genet. 2023;142 (4):553-562. doi: 10.1007/s00439-023-02543-3. PubMed PMID:36943453 .
  3. White, S, Mossfield, T, Fleming, J, Barlow-Stewart, K, Ghedia, S, Dickson, R et al.. Expanding the Australian Newborn Blood Spot Screening Program using genomic sequencing: do we want it and are we ready?. Eur J Hum Genet. 2023; :. doi: 10.1038/s41431-023-01311-1. PubMed PMID:36935418 .
  4. Mighton, C, Clausen, M, Shickh, S, Baxter, NN, Scheer, A, Sebastian, A et al.. How do members of the public expect to use variants of uncertain significance in their health care? A population-based survey. Genet Med. 2023;25 (5):100819. doi: 10.1016/j.gim.2023.100819. PubMed PMID:36919843 .
  5. Gauvreau, CL, Wight, L, Subasri, M, Palmer, A, Hayeems, R, Croker, A et al.. Access to novel drugs and therapeutics for children and youth: Eliciting citizens' values to inform public funding decisions. Health Expect. 2023;26 (2):715-727. doi: 10.1111/hex.13697. PubMed PMID:36639959 PubMed Central PMC10010086.
  6. Luca, S, Clausen, M, Shaw, A, Lee, W, Krishnapillai, S, Adi-Wauran, E et al.. Finding the sweet spot: a qualitative study exploring patients' acceptability of chatbots in genetic service delivery. Hum Genet. 2023;142 (3):321-330. doi: 10.1007/s00439-022-02512-2. PubMed PMID:36629921 PubMed Central PMC9838385.
  7. Majeed, S, Mighton, C, Malkin, D, Bombard, Y. Heath policy guiding the identification, analysis and management of secondary findings for individuals undergoing genomic sequencing: a systematic review protocol. BMJ Open. 2022;12 (12):e065496. doi: 10.1136/bmjopen-2022-065496. PubMed PMID:36549730 PubMed Central PMC9791410.
  8. Mighton, C, Shickh, S, Aguda, V, Krishnapillai, S, Adi-Wauran, E, Bombard, Y et al.. From the patient to the population: Use of genomics for population screening. Front Genet. 2022;13 :893832. doi: 10.3389/fgene.2022.893832. PubMed PMID:36353115 PubMed Central PMC9637971.
  9. Casalino, S, Frangione, E, Chung, M, MacDonald, G, Chowdhary, S, Mighton, C et al.. Genome screening, reporting, and genetic counseling for healthy populations. Hum Genet. 2023;142 (2):181-192. doi: 10.1007/s00439-022-02480-7. PubMed PMID:36331656 PubMed Central PMC9638226.
  10. Frangione, E, Chung, M, Casalino, S, MacDonald, G, Chowdhary, S, Mighton, C et al.. Genome Reporting for Healthy Populations-Pipeline for Genomic Screening from the GENCOV COVID-19 Study. Curr Protoc. 2022;2 (10):e534. doi: 10.1002/cpz1.534. PubMed PMID:36205462 PubMed Central PMC9874607.
Search PubMed

Affiliations & Other Activities

  • Associate Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
  • Member, Board of Directors, American Society of Human Genetics
  • Member, CIHR Institute of Genetics Advisory Board
  • Member, Ontario Genetics Advisory Committee, Health Quality Ontario
  • Member, Board of Directors, Exactis Innovation
  • Associate, Ontario Institute of Cancer Research
  • Co-lead, Societal Values and Patient Engagement Program, the Canadian Centre for Applied Research in Cancer Control
  • Member, Provincial Council for Maternal and Child Health’s Prenatal Screening Advisory Committee
  • Member, Steering Committee of the Canadian Coalition for Genetic Fairness